> ## Documentation Index
> Fetch the complete documentation index at: https://docs.getrivet.ca/llms.txt
> Use this file to discover all available pages before exploring further.

# Depression + anxiety screening in Rivet

> When to screen, what the severity bands tell you, and how to pick between overlapping measures like PHQ-9 vs QIDS or CES-D-R.

The depression and anxiety screening family is the most-used corner of the
template library. PHQ-9 and GAD-7 are the universally expected pair —
insurers ask for them, EFAP referrals often require them, and outcome-
informed therapy treats them as the standard depression and anxiety
measures. Rivet includes three more depression scales (QIDS-SR-16,
CES-D-R) and a social anxiety scale (SPIN) for cases where the standard
pair isn't the right fit.

## When to screen

The common cadence:

* **Intake.** A PHQ-9 + GAD-7 baseline on the first session, often sent
  async ahead of time so they're already filled when you sit down together.
* **Every 2–4 weeks during treatment.** Track response without screening
  burnout. PHQ-9 takes the client about two minutes.
* **Pre/post a discrete intervention.** Around an EMDR target, a CBT
  protocol, a medication change, or any time you want to attribute a
  symptom change to a specific piece of work.
* **Discharge.** Outcome documentation for the chart, for the referrer,
  and for the client to see what changed.

You're free to administer them less often — these are tools, not rules —
but most outcome-informed practices land on something close to this
rhythm.

## What the severity bands tell you

Every measure in this family has a published total-score-to-severity-band
mapping (e.g. PHQ-9: 0–4 Minimal, 5–9 Mild, 10–14 Moderate, 15–19
Moderately severe, 20–27 Severe). Rivet shows you the band live as soon
as the total crosses a threshold.

The bands are interpretive aids, not diagnoses. A PHQ-9 of 14 doesn't mean
the client has Major Depressive Disorder — it means their self-reported
symptoms over the last two weeks fall in the moderate-severity range on a
nine-item screening instrument. The clinical interview is what makes a
diagnosis; the band is what helps you triage attention.

The most useful question to ask about a score is what *changed*. A drop
from 18 to 10 over six weeks is a clinically meaningful response. A flat
14 across three months suggests the current approach isn't moving the
client.

## Picking between depression measures

Rivet includes four self-report depression scales. They cover overlapping
ground; the practical differences:

* **[PHQ-9](/clinical-templates/screening/phq-9)** — Nine items, two-week
  frame, the universal default. Pair with GAD-7. Item 9 surfaces suicidal
  ideation in a single item.
* **[QIDS-SR-16](/clinical-templates/screening/qids-sr-16)** — Sixteen
  items, two-week frame, mirrors DSM-IV-TR symptom domains. Used widely
  in research and outcome-tracking. Item 12 is the suicidality item.
* **[CES-D-R](/clinical-templates/screening/ces-d-r)** — Twenty items,
  past-week frame, covers all nine DSM symptom groups. Often selected
  when there's continuity with prior CES-D documentation. Items 14 and
  15 split death wish and self-harm into two items.
* **[SPIN](/clinical-templates/screening/spin)** — Seventeen items
  specifically for social anxiety / Social Phobia. Past-week frame.
  Different family from the other three; use when the presenting concern
  is social-evaluative anxiety.

If you don't have a preference, start with PHQ-9. It's the expected
default and pairs naturally with GAD-7.

## The risk-flag rule

Every depression measure in this family carries a suicidality item
(sometimes two). Across PHQ-9, QIDS, and CES-D-R, the rule is the same:

<Warning>
  **Any positive answer on a suicidality item warrants follow-up regardless
  of the total score.** A PHQ-9 of 6 with Item 9 answered "Several days"
  matters more than a PHQ-9 of 22 with Item 9 at zero. Rivet surfaces a
  flag in the scoring pill when the cutoff is crossed; the clinical
  judgment about what to do next is yours.
</Warning>

Each per-measure article calls out the specific item(s) that trigger the
flag and how Rivet displays it.

## A note on clinical change

A common practitioner question is "how big a drop counts as real change?"
The convention from the literature varies by measure — a 5-point PHQ-9
drop is often cited (Kroenke 2010 follow-up), and similar conventions
exist for GAD-7 and the others. Rivet doesn't compute "change" between
two responses; the in-session scoring pill shows the current total only.
If you want week-over-week trends, that's the role of
[measurement-based care](/measurement-based-care/index), not the
in-session template.

## Every measure in this section

Twenty-five instruments, grouped by what they are for. Each page carries the
scoring rules, the cutoffs and what a change in score actually means.

### Depression and mood

<CardGroup cols={2}>
  <Card title="PHQ-9" icon="chart-column" href="/clinical-templates/screening/phq-9">
    The default depression measure. Nine items, and Item 9 carries a risk flag.
  </Card>

  <Card title="QIDS-SR-16" icon="chart-column" href="/clinical-templates/screening/qids-sr-16">
    Depression severity with a highest-item rule across the sleep, weight and psychomotor domains.
  </Card>

  <Card title="CES-D-R" icon="chart-column" href="/clinical-templates/screening/ces-d-r">
    Depressive symptoms over the past week, with a longer look-back than the PHQ-9.
  </Card>

  <Card title="WHO-5" icon="chart-column" href="/clinical-templates/screening/who-5">
    Five items on well-being rather than symptoms. Reverse-scored — higher is better.
  </Card>

  <Card title="MDQ" icon="chart-column" href="/clinical-templates/screening/mdq">
    Screens for a history of hypomanic or manic episodes before you treat for depression.
  </Card>
</CardGroup>

### Anxiety, worry and stress

<CardGroup cols={2}>
  <Card title="GAD-7" icon="chart-column" href="/clinical-templates/screening/gad-7">
    The standard anxiety companion to the PHQ-9.
  </Card>

  <Card title="DASS-21" icon="chart-column" href="/clinical-templates/screening/dass-21">
    Depression, anxiety and stress on three separate subscales.
  </Card>

  <Card title="PSWQ" icon="chart-column" href="/clinical-templates/screening/pswq">
    Worry as a trait rather than a symptom — useful in GAD work.
  </Card>

  <Card title="SPIN" icon="chart-column" href="/clinical-templates/screening/spin">
    Social anxiety across fear, avoidance and physiological arousal.
  </Card>

  <Card title="OCI-R" icon="chart-column" href="/clinical-templates/screening/oci-r">
    Obsessive-compulsive symptoms across six dimensions.
  </Card>

  <Card title="PSS-10" icon="chart-column" href="/clinical-templates/screening/pss-10">
    Perceived stress over the last month — appraisal rather than event count.
  </Card>
</CardGroup>

### Trauma

<CardGroup cols={2}>
  <Card title="PCL-5" icon="chart-column" href="/clinical-templates/screening/pcl-5">
    The DSM-5 PTSD checklist. The adult standard.
  </Card>

  <Card title="CPSS-5" icon="chart-column" href="/clinical-templates/screening/cpss-5">
    The pediatric counterpart to the PCL-5, ages 8 to 18.
  </Card>

  <Card title="ITQ" icon="chart-column" href="/clinical-templates/screening/itq">
    The ICD-11 measure, and the one that separates PTSD from Complex PTSD.
  </Card>

  <Card title="ACE" icon="chart-column" href="/clinical-templates/screening/ace">
    Childhood adversity as a count, not a severity score. Read the caveats before using it.
  </Card>
</CardGroup>

### Sleep

<CardGroup cols={2}>
  <Card title="ISI" icon="chart-column" href="/clinical-templates/screening/isi">
    Insomnia severity, with a published 6-point threshold for meaningful change.
  </Card>

  <Card title="PSQI" icon="chart-column" href="/clinical-templates/screening/psqi">
    Sleep quality across seven components over the past month.
  </Card>
</CardGroup>

### Eating

<CardGroup cols={2}>
  <Card title="SCOFF" icon="chart-column" href="/clinical-templates/screening/scoff">
    A five-question screen. Two or more positives warrants a fuller assessment.
  </Card>

  <Card title="EDE-Q" icon="chart-column" href="/clinical-templates/screening/ede-q">
    Eating-disorder psychopathology across four subscales.
  </Card>
</CardGroup>

### Personality, regulation and function

<CardGroup cols={2}>
  <Card title="MSI-BPD" icon="chart-column" href="/clinical-templates/screening/msi-bpd">
    A brief screen for borderline personality features.
  </Card>

  <Card title="BSL-23" icon="chart-column" href="/clinical-templates/screening/bsl-23">
    Borderline symptom severity, tracked over time — the DBT outcome standard.
  </Card>

  <Card title="ERQ" icon="chart-column" href="/clinical-templates/screening/erq">
    Reappraisal and suppression as emotion-regulation strategies.
  </Card>

  <Card title="WHODAS-12" icon="chart-column" href="/clinical-templates/screening/whodas-12">
    Functional disability across six life domains, independent of diagnosis.
  </Card>

  <Card title="K10" icon="chart-column" href="/clinical-templates/screening/k10">
    General psychological distress. A wide net when the presentation is unclear.
  </Card>

  <Card title="MSPSS" icon="chart-column" href="/clinical-templates/screening/mspss">
    Perceived social support from family, friends and a significant other.
  </Card>
</CardGroup>

## Related articles

<CardGroup cols={2}>
  <Card title="What's in the library" icon="layer-group" href="/clinical-templates/overview">
    The three kinds of templates and how scoring works.
  </Card>

  <Card title="Filling a template in-session" icon="users" href="/clinical-templates/in-session-administration">
    The live collaborative flow from picker to PDF.
  </Card>
</CardGroup>
